Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review

Introduction Childhood leukaemia is the most common type of cancer in children and represents among 25% of the diagnoses in children <15 years old. Childhood survival rates have significantly improved within the last 40 years due to a rapid advancement in therapeutic interventions. However, in hi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dyk, Madelé van (VerfasserIn) , Boylan, Chelsea (VerfasserIn) , Michelet, Robin (VerfasserIn) , McLaughlin, Anna Margarete (VerfasserIn) , Kichenadasse, Ganessan (VerfasserIn) , May, Nikki (VerfasserIn) , Ziesenitz, Victoria C. (VerfasserIn) , Anker, Johannes N. Van Den (VerfasserIn) , Groenland, Stefanie L. (VerfasserIn) , Huitema, Alwin D. R. (VerfasserIn) , Steeghs, Neeltje (VerfasserIn) , Mikus, Gerd (VerfasserIn) , Kloft, Charlotte (VerfasserIn) , Tapp, Heather (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: BMJ open
Year: 2022, Jahrgang: 12, Heft: 1, Pages: 1-5
ISSN:2044-6055
DOI:10.1136/bmjopen-2021-053308
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1136/bmjopen-2021-053308
Verlag, kostenfrei, Volltext: https://bmjopen.bmj.com/content/12/1/e053308
Volltext
Verfasserangaben:Madelé van Dyk, Chelsea Boylan, Robin Michelet, Anna M. Mc Laughlin, Ganessan Kichenadasse, Nikki May, Victoria Ziesenitz, Johannes N. Van Den Anker, Stefanie L. Groenland, Alwin D. R. Huitema, Neeltje Steeghs, Gerd Mikus, Charlotte Kloft, Heather Tapp

MARC

LEADER 00000caa a2200000 c 4500
001 1812526121
003 DE-627
005 20230427070223.0
007 cr uuu---uuuuu
008 220801s2022 xx |||||o 00| ||eng c
024 7 |a 10.1136/bmjopen-2021-053308  |2 doi 
035 |a (DE-627)1812526121 
035 |a (DE-599)KXP1812526121 
035 |a (OCoLC)1341464473 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dyk, Madelé van  |e VerfasserIn  |0 (DE-588)1264091184  |0 (DE-627)1812528523  |4 aut 
245 1 0 |a Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias  |b protocol for a systematic review  |c Madelé van Dyk, Chelsea Boylan, Robin Michelet, Anna M. Mc Laughlin, Ganessan Kichenadasse, Nikki May, Victoria Ziesenitz, Johannes N. Van Den Anker, Stefanie L. Groenland, Alwin D. R. Huitema, Neeltje Steeghs, Gerd Mikus, Charlotte Kloft, Heather Tapp 
264 1 |c 2022 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.08.2022 
520 |a Introduction Childhood leukaemia is the most common type of cancer in children and represents among 25% of the diagnoses in children <15 years old. Childhood survival rates have significantly improved within the last 40 years due to a rapid advancement in therapeutic interventions. However, in high-risk groups, survival rates remain poor. Pharmacokinetic (PK) data of cancer medications in children are limited and thus current dosing regimens are based on studies with small sample sizes. In adults, large variability in PK is observed and dose individualisation (plasma concentration guided dosing) has been associated with improved clinical outcomes; whether this is true for children is still unknown. This provides an opportunity to explore this strategy in children to potentially reduce toxicities and ensure optimal dosing. This paper will provide a protocol to systematically review studies that have used dose individualisation of drugs used in the treatment of childhood leukaemias. - Methods and analysis Systematic review methodology will be applied to identify, select and extract data from published plasma guided dosing studies conducted in a paediatric leukaemia cohort. Databases (eg, Ovid Embase, Ovid MEDLINE, Ovid Cochrane) and clinical trial registries (CENTRAL, ClinicalTrials.gov and ISRCTN) will be used to perform the systematic literature search (up until February 2021). Only full empirical studies will be included, with primary clinical outcomes (progression-free survival, toxicities, minimal residual disease status, complete cytogenetic response, partial cytogenetic response and major molecular response) being used to decide whether the study will be included. The quality of included studies will be undertaken, with a subgroup analysis where appropriate. - Ethics and dissemination This systematic review will not require ethics approval as there will not be collection of primary data. Findings of this review will be made available through publications in peer-reviewed journals and conference presentations. Gaps will be identified in current literature to inform future-related research. - PROSPERO registration number CRD42021225045. 
650 4 |a chemotherapy 
650 4 |a clinical pharmacology 
650 4 |a leukaemia 
650 4 |a paediatric oncology 
650 4 |a paediatrics 
700 1 |a Boylan, Chelsea  |e VerfasserIn  |4 aut 
700 1 |a Michelet, Robin  |e VerfasserIn  |4 aut 
700 1 |a McLaughlin, Anna Margarete  |d 1993-  |e VerfasserIn  |0 (DE-588)1236766040  |0 (DE-627)1762548763  |4 aut 
700 1 |a Kichenadasse, Ganessan  |e VerfasserIn  |4 aut 
700 1 |a May, Nikki  |e VerfasserIn  |4 aut 
700 1 |a Ziesenitz, Victoria C.  |d 1985-  |e VerfasserIn  |0 (DE-588)1036795640  |0 (DE-627)751696099  |0 (DE-576)386865132  |4 aut 
700 1 |a Anker, Johannes N. Van Den  |e VerfasserIn  |4 aut 
700 1 |a Groenland, Stefanie L.  |e VerfasserIn  |4 aut 
700 1 |a Huitema, Alwin D. R.  |e VerfasserIn  |4 aut 
700 1 |a Steeghs, Neeltje  |e VerfasserIn  |4 aut 
700 1 |a Mikus, Gerd  |e VerfasserIn  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 aut 
700 1 |a Kloft, Charlotte  |e VerfasserIn  |0 (DE-588)1133048838  |0 (DE-627)888200234  |0 (DE-576)489083722  |4 aut 
700 1 |a Tapp, Heather  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t BMJ open  |d London : BMJ Publishing Group, 2011  |g 12(2022), 1, Artikel-ID e053308, Seite 1-5  |h Online-Ressource  |w (DE-627)654747075  |w (DE-600)2599832-8  |w (DE-576)339269340  |x 2044-6055  |7 nnas  |a Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias protocol for a systematic review 
773 1 8 |g volume:12  |g year:2022  |g number:1  |g elocationid:e053308  |g pages:1-5  |g extent:5  |a Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias protocol for a systematic review 
856 4 0 |u https://doi.org/10.1136/bmjopen-2021-053308  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://bmjopen.bmj.com/content/12/1/e053308  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20220801 
993 |a Article 
994 |a 2022 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 910000  |d 910100  |d 50000  |e 910000PM110903137  |e 910100PM110903137  |e 50000PM110903137  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 12 
998 |g 1036795640  |a Ziesenitz, Victoria C.  |m 1036795640:Ziesenitz, Victoria C.  |d 910000  |d 910500  |e 910000PZ1036795640  |e 910500PZ1036795640  |k 0/910000/  |k 1/910000/910500/  |p 7 
999 |a KXP-PPN1812526121  |e 417473559X 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"5 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"London","dateIssuedKey":"2011","publisher":"BMJ Publishing Group","dateIssuedDisp":"2011-"}],"id":{"issn":["2044-6055"],"zdb":["2599832-8"],"eki":["654747075"]},"pubHistory":["2011 -"],"part":{"extent":"5","volume":"12","text":"12(2022), 1, Artikel-ID e053308, Seite 1-5","issue":"1","pages":"1-5","year":"2022"},"disp":"Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias protocol for a systematic reviewBMJ open","note":["Gesehen am 02.10.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"654747075","language":["eng"],"title":[{"title":"BMJ open","title_sort":"BMJ open"}]}],"origin":[{"dateIssuedDisp":"2022","dateIssuedKey":"2022"}],"id":{"doi":["10.1136/bmjopen-2021-053308"],"eki":["1812526121"]},"name":{"displayForm":["Madelé van Dyk, Chelsea Boylan, Robin Michelet, Anna M. Mc Laughlin, Ganessan Kichenadasse, Nikki May, Victoria Ziesenitz, Johannes N. Van Den Anker, Stefanie L. Groenland, Alwin D. R. Huitema, Neeltje Steeghs, Gerd Mikus, Charlotte Kloft, Heather Tapp"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 01.08.2022"],"recId":"1812526121","language":["eng"],"title":[{"title_sort":"Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias","subtitle":"protocol for a systematic review","title":"Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Dyk, Madelé van","given":"Madelé van","family":"Dyk"},{"family":"Boylan","given":"Chelsea","roleDisplay":"VerfasserIn","display":"Boylan, Chelsea","role":"aut"},{"given":"Robin","family":"Michelet","role":"aut","roleDisplay":"VerfasserIn","display":"Michelet, Robin"},{"given":"Anna Margarete","family":"McLaughlin","role":"aut","display":"McLaughlin, Anna Margarete","roleDisplay":"VerfasserIn"},{"family":"Kichenadasse","given":"Ganessan","display":"Kichenadasse, Ganessan","roleDisplay":"VerfasserIn","role":"aut"},{"family":"May","given":"Nikki","display":"May, Nikki","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Ziesenitz, Victoria C.","roleDisplay":"VerfasserIn","given":"Victoria C.","family":"Ziesenitz"},{"family":"Anker","given":"Johannes N. Van Den","roleDisplay":"VerfasserIn","display":"Anker, Johannes N. Van Den","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Groenland, Stefanie L.","given":"Stefanie L.","family":"Groenland"},{"given":"Alwin D. R.","family":"Huitema","role":"aut","roleDisplay":"VerfasserIn","display":"Huitema, Alwin D. R."},{"display":"Steeghs, Neeltje","roleDisplay":"VerfasserIn","role":"aut","family":"Steeghs","given":"Neeltje"},{"family":"Mikus","given":"Gerd","roleDisplay":"VerfasserIn","display":"Mikus, Gerd","role":"aut"},{"given":"Charlotte","family":"Kloft","role":"aut","display":"Kloft, Charlotte","roleDisplay":"VerfasserIn"},{"display":"Tapp, Heather","roleDisplay":"VerfasserIn","role":"aut","family":"Tapp","given":"Heather"}]} 
SRT |a DYKMADELEVPLASMACONC2022